Combinations Required to Further Advance Adoptive T-Cell Therapy – OncLive
OncLive |
Combinations Required to Further Advance Adoptive T–Cell Therapy
OncLive A variety of adoptive T–cell therapy strategies have shown promise in clinical trials with recent FDA approvals granted to chimeric antigen receptor (CAR)-modified T–cell therapies, representing the potential for future combination strategies … |
